HR 2197 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
No 340B Savings for Transgender Care Act
To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes.
Summary
The No 340B Savings for Transgender Care Act amends the 340B drug discount program by adding restrictions on how covered entities can use savings from discounted drug prices. The bill prohibits covered entities from using funds derived from the difference between 340B ceiling prices and actual drug acquisition costs to pay for sex reassignment surgeries or hormone treatments furnished for gender alteration of transgender individuals. The restriction applies only to savings generated through the 340B program discount mechanism, not to other funding sources that covered entities may use for these services.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
10 cosponsors
- Rep. Bice, Stephanie I. [R-OK-5] (R-OK)
- Rep. Crenshaw, Dan [R-TX-2] (R-TX)
- Rep. Ezell, Mike [R-MS-4] (R-MS)
- Rep. Finstad, Brad [R-MN-1] (R-MN)
- Rep. Fry, Russell [R-SC-7] (R-SC)
- Rep. Moore, Barry [R-AL-1] (R-AL)
- Rep. Rose, John W. [R-TN-6] (R-TN)
- Rep. Rulli, Michael A. [R-OH-6] (R-OH)
- Rep. Scott, Austin [R-GA-8] (R-GA)
- Rep. Williams, Roger [R-TX-25] (R-TX)
Money behind the sponsor
Top reported contributors to Dusty Johnson’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $68,175
- SANFORD HEALTH $31,000
- STATE OF SOUTH DAKOTA $28,050
- AVERA HEALTH $18,200
- VANTAGE POINT $15,205
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Dusty Johnson → · Outside spending →
Actions (2)
- Mar 18, 2025 Referred to the House Committee on Energy and Commerce. · house
- Mar 18, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
March 18, 2025
Mr. Johnson of South Dakota (for himself, Mr. Austin Scott of Georgia, Mr. Crenshaw, Mr. Rulli, Mr. Ezell, Mrs. Bice, Mr. Moore of Alabama, and Mr. Rose) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “No 340B Savings for Transgender Care Act”.
SEC. 2. PROHIBITION ON USE OF 340B SAVINGS FOR SERVICES DESCRIBED FOR TRANSGENDER INDIVIDUALS.
(a) Prohibition on Use of 340B Savings for Services Described.— Section 340B(a)(4) of the Public Health Service Act (42 U.S.C. 256b(a)(5)) is amended by adding at the end the following:
“(E) Prohibition on use of 340b savings for services described.—A covered entity participating in the program under this section may not use any funds derived from the difference between the 340B ceiling price and the actual acquisition cost of covered outpatient drugs to pay for services described.
“(i) Definitions.—For purposes of this subsection—
“(I) Covered entity.—The term ‘covered entities’ has the meaning given such term in section 340B(a)(4).
“(II) Services described.—The term ‘services described’ means— “(aa) sex reassignment surgeries furnished for the purpose of the gender alteration of a transgender individual; and “(bb) hormone treatments furnished for the purpose of the gender alteration of a transgender individual.”. <all>
Comments